CHWY
Chewy, Inc.
NYSE · Consumer Cyclical · Specialty Retail · US
$20.62
−1.34%Sep 9, 2026, 15:29 UTC
Chewy reported fiscal second-quarter results for the period ended August 2, with adjusted EPS of $0.36 and net sales of $3.33 billion, roughly in line with analyst expectations.
Source:Sep 9, 2026, 15:29 UTC
Chewy's CEO stated that consumer spending pressure will continue through the end of the year, with no significant consumption recovery expected within the year.
Source:Sep 9, 2026, 11:05 UTC
Chewy, Inc. reported Q2 FY2026 net sales of $3.33 billion, up 7.3% year-over-year, with net income of $80.5 million and diluted EPS of $0.20.
Aug 26, 2026, 13:00 UTC
Jaguar Health initiated the commercial launch of Neonorm Dog, a non-prescription plant-based product for dogs, and plans to make it available through Amazon and Chewy soon.
Source:Aug 3, 2026, 09:08 UTC
Dimensional Fund Advisors LP increased its stake in Chewy by 49.9% during the second quarter of 2026, acquiring 578,801 additional shares, according to a recent SEC filing.
Source:Jul 15, 2026, 12:45 UTC
California Attorney General Rob Bonta secured the public release of a largely unredacted injunction filing in the state's 2022 antitrust lawsuit against Amazon, alleging the company pressured vendors to raise prices on rival platforms.
Source:Jun 24, 2026, 00:00 UTC
Chewy, Inc. amended its existing ABL credit facility to extend the maturity date.
Jun 24, 2026, 00:00 UTC
Chewy, Inc. entered into a $600 million seven-year senior secured term loan credit facility with a syndicate of lenders led by JPMorgan Chase Bank, N.A.
Jun 22, 2026, 15:01 UTC
Chewy acquired Modern Animal to strengthen its pet healthcare platform.
Source:Jun 17, 2026, 07:47 UTC
Chewy reported its Q1 CY2026 earnings with revenue of $3.36 billion and adjusted EPS of $0.43.
Source:Jun 10, 2026, 00:00 UTC
Chewy, Inc. reported its Q1 FY2026 financial results with net sales of $3.36 billion and net income of $94.8 million.